RxDoctor Payments Data

Samantha Craighead

Physician Assistant · Goodlettsville, TNNPI 1023528262

Payments from drug & device makers

$8,715in general payments, 2019–2025

Across 370 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$1K
  • UCB, Inc.$900
  • Novartis$595
  • Mallinckrodt Hospital Products Inc.$571
  • Johnson & Johnson$477
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$8,53198%
  • Education$1842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,715 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept113$884,464
Orencia ClickjectAbatacept57$337,734
Humira(Cf) PenAdalimumab38$280,053
BenlystaBelimumab47$251,465
Xeljanz XrTofacitinib Citrate41$233,073
RinvoqUpadacitinib35$219,934
Taltz AutoinjectorIxekizumab28$212,051
Cyltezo(Cf) PenAdalimumab-Adbm12$89,299
ProliaDenosumab30$51,643
Hydroxychloroquine Sulfate878$30,636
Leflunomide396$28,473
MethotrexateMethotrexate Sodium548$15,425
Mycophenolate Mofetil77$9,001
Prednisone472$2,257
Duloxetine Hcl105$1,943

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBenlysta$195$251,46547 claims
AbbVieRinvoq$1,042$219,93435 claims
AmgenProlia$2,151$51,64330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Goodlettsville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →